ProPhase Labs, Inc. Common Stock, Dividends, Per Share, Cash Paid
ProPhase Labs, Inc. (PRPH) had Common Stock, Dividends, Per Share, Cash Paid of $0.30 per share as of 2022-05-09, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareCashPaid · last filed 2024-03-29
- ProPhase Labs, Inc. common stock, dividends, per share, cash paid for fiscal 2021 was $0.30.
| Period end | Common Stock, Dividends, Per Share, Cash Paid | Common Stock, Dividends, Per Share, Cash Paid 0 month | Common Stock, Dividends, Per Share, Cash Paid 12 month |
|---|---|---|---|
| 2022-05-09 | $0.30 10-K · filed 2024-03-29 | ||
| 2022-02-14 | $0.30 10-K · filed 2024-03-29 | ||
| 2021-12-31 | $0.30 10-K · filed 2023-03-29 | ||
| 2021-05-13 | $0.30 10-K · filed 2022-03-31 | ||
| 2021-02-14 | $0.30 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 10-Q · filed 2021-08-13 | ||
| 2019-11-20 | $0.25 10-K · filed 2021-03-31 | ||
| 2018-12-24 | $0.25 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |